{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:17:27Z","timestamp":1705018647832},"reference-count":11,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World j. surg."],"published-print":{"date-parts":[[1985,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>This is a preliminary report of the Southwest Oncology Group in which therapy is randomized by estrogen receptor (ER) data. Estrogen receptor\u2010negative patients receive either 1 or 2 years of cyclophosphamide, methotrexate, 5\u2010fluorouracil, vincristine, and prednisone (CMFVP). The ER\u2010positive group receive CMFVP for 1 year and\/or hormonal therapy. The findings to date include: (a) Estrogen receptor\u2010positive patients have a significantly longer disease\u2010free interval compared to ER\u2010negative patients<\/jats:bold> (<jats:bold><jats:italic>p<\/jats:italic><\/jats:bold> =<jats:bold>0.004); (b) there is no significant difference in diseasefree interval for ER\u2010negative patients who receive either 1 or 2 years of CMFVP; (c) the data for ER\u2010positive patients is too preliminary to report for disease\u2010free or total survival; and (d) toxicity is acceptable because of frequent monitoring and examinations which result in the low percentage of life\u2010threatening toxicity<\/jats:bold>.<\/jats:p>","DOI":"10.1007\/bf01655187","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T02:38:26Z","timestamp":1115519906000},"page":"723-727","source":"Crossref","is-referenced-by-count":6,"title":["Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor status"],"prefix":"10.1002","volume":"9","author":[{"given":"Saul E.","family":"Rivkin","sequence":"first","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"William A.","family":"Knight","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"McDivitt","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Cruz","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Foulkes","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Kent","family":"Osborne","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol J.","family":"Fabian","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Costanzi","sequence":"additional","affiliation":[{"name":"Tumor Institute Swedish Hospital Medical Center 1221\u00a0Madison Street 98104 Seattle Washington USA"},{"name":"Department of Medical Oncology University of Texas, and University of Texas Health Science Center San Antonio Texas"},{"name":"Department of Medical Oncology University of Texas Galveston Texas"},{"name":"Department of Pathology Jewish Hospital of St. Louis St. Louis Missouri"},{"name":"Department of Medical Oncology University of Kansas Kansas City Kansas USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1985,10]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"4669","article-title":"Estrogen receptor: An independent prognostic factor for early recurrence in breast cancer","volume":"37","author":"Knight W.","year":"1977","journal-title":"Cancer Res."},{"key":"e_1_2_1_3_1","first-page":"392","article-title":"Absent estrogen receptor and decreased survival in human breast cancer","volume":"19","author":"Knight W.","year":"1978","journal-title":"Proc. AACR\u2010ASCO"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197508)36:2 <638::AID-CNCR2820360805>3.0.CO;2-S"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P"},{"key":"e_1_2_1_6_1","volume-title":"Clinical Research Department","year":"1977"},{"key":"e_1_2_1_7_1","first-page":"1431","article-title":"Phase II study of tamoxifen: Report of 74 patients with stage IV breast cancer","volume":"60","author":"Lerner H.","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_8_1","first-page":"1145","article-title":"Antiestrogen\u2010induced remissions in stage IV breast cancer","volume":"60","author":"Manni A.","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_9_1","first-page":"1437","article-title":"Therapeutic use of tamoxifen in advanced breast cancer: Correlation with biochemical parameters","volume":"60","author":"Morgan L.","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_10_1","first-page":"1451","article-title":"Evaluation of tamoxifen dose in advanced breast cancer: A progress report","volume":"60","author":"Tormey D.","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_11_1","first-page":"423","article-title":"Combination chemotherapy (CMFVP) vs L\u2010PAM for operable breast cancer with positive axillary nodes","volume":"50","author":"Glucksberg H.","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"e_1_2_1_12_1","first-page":"501","volume-title":"Current Controversies in Breast Cancer","author":"Rivkin S.E.","year":"1984"}],"container-title":["World Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01655187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01655187\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF01655187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01655187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T15:19:14Z","timestamp":1704986354000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/BF01655187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["10.1007\/BF01655187"],"URL":"https:\/\/doi.org\/10.1007\/bf01655187","archive":["Portico"],"relation":{},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}